Faculty & Agenda

Agenda & Faculty

ODAC Dermatology Conference | January 17 – 20, 2020 | Orlando, FL

Earn Up to 31 AMA PRA Category 1 Credits™


Be An Expert Among Experts at ODAC – Annual Updates and Fresh Pearls in Medical, Aesthetic and Surgical Dermatology

At the 2020 ODAC Dermatology Conference, you will meet the innovators who are shaping the future of Dermatology throughout the globe. ODAC is curated, organized, and presented by visionary pioneers in Medical, Aesthetic, and Surgical Dermatology. Gain direct access to our elite, world renowned faculty during clinically relevant CME lectures, hands-on workshops, networking opportunities and live demonstrations. View the comprehensive, cutting-edge 2020 agenda below.

Agenda and faculty subject to change.

FRIDAY, JANUARY 17TH

PRE-CONFERENCE WORKSHOPS

8:00 AM-12:00 PM

Comprehensive Aesthetic Rejuvenation

New this year - Dr. Shino Bay Aguilera will lead a brand new workshop on aesthetic rejuvenation focusing on symmetry and enhancing beauty beyond ratios. This session will explore the rheological properties of injectables and avoiding/managing aesthetic complications. The course includes live demonstration on contouring with poly-l-latic acid and hyaluronic acid fillers. The session will wrap up with the dos and don'ts of using social media and how to attract the right patients.  

Shino Bay Aguilera, DO
1:00-3:00 PM

Changes to Your MOC Requirements: What Every Dermatologist Should Know About CertLink

The American Board of Dermatology launches in January 2020 a new testing platform for all board certified dermatologists.  Instead of a one-time, sit-down, high stakes  examination where dermatologists must travel and take off time from practice, board certified dermatologists can now take test questions in the convenience of their home or office, at their computer at various times throughout the year.  This longitudinal testing platform is called CertLink.  It is designed to not only test medical knowledge of the dermatologist, but also to build medical knowledge in a “test to competence” type model.  It also is designed to keep dermatologists up to date with the latest articles from the various dermatology subspecialties.  This workshop is designed to be a walk-through of the new testing platform, to demonstrate its design, rationale, and navigation.

Erik Stratman, MD
1:00-5:00 PM

Derm In-Review Board Review in Partnership with George Washington University

Medical Dermatology for the Boards with Sima Jain, MD
Pediatric Dermatology for the Boards with Yasmine Kirkorian, MD
Basic Science for the Boards with Jonathan Zippin, MD
Brain Break Panel with All Faculty and Special Guests 
Medical Dermatology for the Boards with Justin Finch, MD
Procedural Derm for the Boards with Vishal Patel, MD 

Adam Friedman, MD, Sima Jain, MD, Yasmine Kirkorian, MD, Jonathan Zippin, MD, Justin Finch, Vishal Patel, MD and special guests
1:30 - 3:30PMGENERAL SESSION I
WelcomeODAC Conference Chairs
You Don't Know JAK: An Introduction to the JAK/STAT Pathway to Better Understand Therapeutic Implications
This lecture is designed to review the JAK/STAT signaling pathway in normal immune biology. We will explore the players involved in the pathway, their normal function, and discuss why inhibiting this pathway would be helpful for treating inflammatory diseases of the skin.
Jonathan Zippin, MD
Minimizing Surgical Scars - Pearls from the Expert

When planning elective surgical excisions or reconstructive extirpative effects, it is important to consider a multitude of factors that influence the outcome and final resultant scar, and final cosmetic result. Dr. Gotkin will discuss planning elective surgical excisions to yield the best scar and cosmetic results. In addition he will examine how to plan the reconstruction of extirpative or traumatic defects to yield the best cosmetic result.

Robert Gotkin, MD
How Do I Treat Rosacea in 2020
During this session, Dr. Stein-Gold will provide an overview of the pathogenesis of rosacea, review current best treatment practices and explore the drugs currently in development.
Linda Stein-Gold, MD
The Utility of Dermoscopy in Challenging Clinical CasesSima Jain, MD
New and Emerging Therapies in Dermatology: What’s New in the Medicine Chest - Part 1Leon Kircik, MD
3:30 PMCOFFEE BREAK

Meet and Greet with Poster Authors 
AFTERNOON WORKSHOPS
3:35 - 4:20 PMChallenging Cases in Pediatric Dermatology

Who's afraid of the big bad wolves in pediatric dermatology?  This case-based section will focus on the BAD guys you don't want to miss in your pediatric patients. BAD rashes, BAD bumps, and BAD fads. The session is geared at the general dermatologist who sees pediatric patients.

Yasmine Kirkorian, MD
3:35 - 4:20 PMMerkel Cell Carcinoma: Current Concepts in Diagnosis and Management
Merkel cell carcinoma (MCC) is a rare, but aggressive skin cancer that affects nearly 2000 patients per year. Recent advances in translational medicine have provided insights into the biology of MCC, as well as novel diagnostic tools and therapeutic modalities. This session will review recent developments in the clinical management of MCC, including the role of diagnostic imaging, sentinel lymph node biopsy, and the Merkel cell polyoma virus serum antibody test. We will also cover recently approved therapeutic strategies, including the use of immune-checkpoint inhibitors (ICIs) as front-line therapy for advanced disease, as well as emerging use of ICIs in the neo-adjuvant and adjuvant setting.

David Miller, MD
3:35 - 4:20 PMTips and Tricks in the Diagnosis and Management of Cutaneous Lupus and Other Cutaneous Rheumatologic DiseasesErik Stratman, MD
4:30 - 6:30 PMGENERAL SESSION II - Featuring Controversies & Hot Topics in Medical, Surgical, and Aesthetic Dermatology - Rapid Fire Round

Controversies in Photoprotection

Photoprotective measures, such as sunscreen and clothing, are central to limiting the harmful effects of ultraviolet radiation on the skin. Yet, proper adherence has been impeded by numerous controversies related to and limitations of our current sunscreen armament. This session will help debunk common misconceptions and highlight new innovations in sunscreen technology.

Adam Friedman, MD
High Amplitude Electromagnetic Fields - A New Player in Dermatology

High amplitude electrical fields are being applied to sebaceous hyperplasia, warts, and seborrheic keratoses. Following this session, attendees will be able to understand the role of pulsed electrical fields in management of common dermatologic concerns.

Vic Ross, MD
Updates & Controversies in Hair Loss
During this lecture, Dr. McMichael will examine the most recent interventional treatments in hair loss and the concept of follicular rescue.

Amy McMichael, MD

Recent Controversies in Pediatric Dermatology (Systemic Therapies)

Pediatric patients with severe skin disease should be treated with systemic agents however barriers to treatment include (1) drugs are often off-label (2) perceived increased risk of treating children and (3) dosing variation in children compared to adults. This talk will review on and off-label systemic treatments in children and provide pearls for selection of systemic agents for severe atopic dermatitis, psoriasis and other inflammatory skin diseases in children.

Yasmine Kirkorian, MD

Full-Field Ablative Resurfacing: Is the Pendulum Swinging Back?

This session will show the use of full-field erbium 2940nm resurfacing for more severe cases of etched-in lines (particularly peri-oral). Dr. Cohen will explore peri-oral scales to help quantify severity of lines, demonstrate the technique, and identification of erbium full-field resurfacing endpoints, and show before and after photos, as well as what to expect in the healing process

Joel Cohen, MD

Infectious Diseases to Watch in 2020

Measles, flood-related skin disorders, TIBOLA, and antibiotic resistance have all made recent headlines. This rapid-fire review will alert the audience to these and other diseases to watch for in 2020.

Justin Finch, MD

The Role of Fractional Technologies in Aesthetics - A Conversation with the Experts

This session will highlight the many uses of fractional technologies, including fractional non-ablative, fractional ablative, fractional RF, Fractional microfocused ultrasound

Jeremy Green, MD; Vic Ross, MD; Joel Cohen, MD
Live DemonstrationsSusan Weinkle, MD; Jackie Yee, MD
Facial Anatomy Evaluation & the Successful Rejuvenation PlanSusan Weinkle, MD; Jackie Yee, MD
Injectables Demo - Upper FaceSusan Weinkle, MD; Jackie Yee, MD
Injectables Demo - Mid FaceSusan Weinkle, MD; Jackie Yee, MD
Injectables Demo - Lower FaceSusan Weinkle, MD; Jackie Yee, MD
EVENING ACTIVITIES
6:30 PMWelcome Reception in Exhibit Hall - Registered Attendees Only

SATURDAY, JANUARY 18

7:20 AMBREAKFAST WORKSHOPS - First come, first served. Breakfast is served at 7:20 AM.

Advanced Techniques for Reconstruction of Skin Cancer Defects

This workshop will focus on reconstruction strategies for skin cancer defects on the nose and central face. Planning and executing repairs on the nose and central face by taking into account cosmetic units, anatomic junction lines, relaxed skin tension lines, tissue laxity, and free margins will be discussed.

Desiree Ratner, MD; Robert Gotkin, MD

Not All Emollients are Created Equal: New Learnings on the Role of Colloidal Oatmeal in Managing Eczema

This workshop will highlight the latest data supporting the use of colloidal oatmeal in the treatment of atopic dermatitis and an impaired skin barrier. Clinical efficacy and safety will be emphasized along with new insights on the impact of oat on skin’s microbiome.

Adam Friedman, MD

Bridging Rheumatology and Dermatology Goals in Education: A Comprehensive Examination of COSENTYX® (secukinumab) Clinical Evidence

Leon Kircik, MD and Andrew Sulich, MD
Paving the Path: Exploring a Treatment Option for Patients with Moderate to Severe Hidradenitis SuppurativaJoslyn Kirby, MD, MS
8:30AM - 10:00AMGENERAL SESSION I
An Update on Acne TreatmentsLinda Stein Gold, MD
What on Earth is That? Interactive Case-Based Expert PanelAdam Friedman, MD; Justin Finch, MD
Current and Emerging Management Strategies for Vitiligo

This presentation will address recent discoveries in vitiligo that have influenced the way that we diagnose and manage patients. Clinical trial results for vitiligo are promising, and new treatments are on the horizon. Current approaches to management and their comparative efficacy will be outlined, and emerging targeted therapies will be characterized. The goal is to empower attendees to approach vitiligo in a way that will lead to improved outcomes for their patients.

John Harris, MD

Resurfacing: Recognizing and Treating Adverse Events

This session will show an overview of potential complications that may be seen with ablative resurfacing. Dr. Cohen will review frequently encountered issues such as post-inflammatory erythema, sometimes seen issues such as post-inflammatory hyperpigmentation and rare but troublesome issues such as pigment loss, infection, or even reactive processes like keratoacanthoma.

Joel Cohen, MD
Non-Ablative 1927nm Thulium Laser DemonstrationJeremy Green, MD: Joel Cohen, MD
10:00 AMCOFFEE BREAK IN THE EXHIBIT HALL
10:30AM - 12:15PMGENERAL SESSION II

New and Emerging Therapies for Advanced Non-Melanoma Skin Cancer

This session will discuss advances in treatment, including the use of targeted therapies and immunotherapy, for advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma.  Dr. Ratner will discuss the role of targeted therapies in the treatment of advanced basal cell carcinoma, the role of immunotherapy in treating advanced squamous cell carcinoma and the role of systemic therapy for advanced Merkel cell carcinoma.

Desiree Ratner, MD

Complex Med Derm Cases in SOC Patients: Diagnostic Clues & Treatment Pearls
A review literature on hyperpigmentation, keloids and acne in skin of color will take place during this lecture along with discussion of the current treatment options and pitfalls of treatment for skin disease in patients of color.

Amy McMichael, MD

Male Aesthetics: Aging, Masculinity, Beauty, and Treatment Implications

This session will highlight the behavioral and biologic differences in men and women and how they impact cosmetic treatment. Treatment tips will be shared with regards to the unique challenges treating a male patient.

Terrence Keaney, MD
Therapeutic Updates in Melanoma: IO for Earlier Stage Melanoma

Immuno-Oncology (IO) strategies have profoundly changed the therapeutic landscape for melanoma. Originally approved by the FDA for Stage IV disease, immune checkpoint inhibitors (ICIs) - for example, the anti-PD-1 antibodies pembrolizumab and nivolumab - have recently been approved for use for Stage III disease in the adjuvant setting. Ongoing trials are investigating the use of ICIs as neoadjuvant therapy, as well as in patients with high-risk Stage II disease in the adjuvant setting. As ICI therapy expands to more patients with melanoma, an understanding of the emerging use of IO strategies is paramount for all dermatologists. Dr. Miller will discuss the current indications of ICIs in patients with melanoma and the evolving treatment strategies for patients with earlier stage melanoma.

 

David Miller, MD
Er:YAG & Nd:YAG Laser Combination DemonstrationJanine Hopkins, MD
High Intensity Focused Electro-Magnetic Technology (HIFEM) Live DemonstrationTBA
12:15PMLUNCH BREAK IN THE EXHIBIT HALL - Registered Attendees Only
Lunch Roundtable Discussions in the Exhibit Booth 307 - Introducing New Seysara™ (sarecycline) Tablets
WORKSHOPS
12:15 PM

Dupixent® (dupilumab) Product Theater (Lunch is provided at 12:15 PM)

Vivian Y. Shi, MD
12:30 PMThe Diagnosis and Treatment of Cutaneous Fungal Infections (Lunch is not provided.)Adam Friedman, MD
1:30PM - 3:30PMGENERAL SESSION III
Co-Morbidities in Psoriasis Relating to Cardiovascular Issues

This lecture will cover the relationship between Psoriasis and Cardiovascular issues especially relating to mutual cytokines to both. In addition, Dr. Menter will discuss large coronary artery calcium score study done in psoriasis.

 

Alan Menter, MD
What is NOT Vitiligo

Many conditions of the skin affect its pigment, and those that induce depigmentation or hypopigmentation may be confused for vitiligo. In this presentation, Dr. Harris will compare and contrast the presentation of vitiligo with its mimics, highlighting key clinical features to aid in improved diagnosis and timely management.

John Harris, MD

An Update on Rhinophyma

Rhinophyma, considered to be a form of rosacea, is mainly seen in elderly white males. Easy to identify, as an erythematous bulbous nose with an overgrowth of sebaceous glands, its exact etiology remains elusive. The psychosocial manifestations of this condition can be grave. Dermatologists must become familiar with this entity, and well-versed in therapeutic options.  Dr. Sarnoff will delve into how to identify rhinophyma, theories regarding the etiology of rhinophyma, surgical treatment modalities, medical treatment modalities and the newest research into drugs that hold promise for this cosmetically deformative disease.

Deborah Sarnoff, MD
New and Emerging Therapies in Dermatology: What's New in the Medicine Chest - Part 2Leon Kircik, MD
An Update on Lasers and Light-Based Devices for Vascular ConditionsJeremy Green, MD
Injectables Live Demonstration - Focus on Male PatientsSusan Weinkle, MD - Jeremy Green, MD - Terrence Keaney, MD (Moderator)
3:30PMCOFFEE BREAK IN THE EXHIBIT HALL
3:30 - 4:15PMAFTERNOON RESIDENT WORKING GROUP
Developing New Approaches to Caring for LGBTQ+ Patients 
This session will provide attendees with new strategies for providing competent dermatologic care to LGBTQ+ patients.  Topics to be covered include health disparities among LGBTQ+ populations, unique risks and comorbidities these patient populations face and how they may interact with dermatologic disease, current medical advances in LGBTQ+ health and how they impact dermatology and strategies to achieve sensitivity and nuance in the discussion of sexuality and gender identity.

Angelo Landriscina, MD
4:30-5:30 PMAFTERNOON WORKSHOPS

Dermoscopy Essentials for Residents & Practicing Physicians

 

Open to Practicing Dermatologists, Residents & Fellows Only

Sima Jain, MD
Through the Looking Glass: A First Hand Account of the Severe Atopic Dermatitis ExperienceAdam Friedman, MD; Jason Lee-Llacer, MD; Agnes Abeleda, RN
PhotoDynamic Therapy: Therapeutic Insights And Considerations For 2020 & BeyondJoel Cohen, MD; James Spencer, MD
5:30-7:30 PMDINNER SYMPOSIUM AND EVENING EVENTS
5:30 PMThe Art of Innovation: Introducing the Latest Advancements from Galderma with interactive GIA and live demonstrationsJoel Cohen, MD and Jeremy Green, MD
5:30 PMNew Cosmeceuticals from La Roche-Posay and Skinceuticals with product distributionKavita Mariwalla, MD
7:30 PMFaculty DinnerBy Invitation Only

SUNDAY, JANUARY 19

7:20 AMBREAKFAST WORKSHOPS - First come, first served. Breakfast is served at 7:20 AM.

Getting Practical about Pruritus: Diagnostic Dilemmas and Therapeutic Strategies

Chronic pruritus, arising idiopathically or in association with cutaneous or systemic disease, is often disabling. Successful treatment has been a challenge, though advances in our understanding of the underlying physiology and pathophysiology of itch accompanied by targeted therapeutic approaches are improving our ability to put up a good fight. This goal of this lecture it to provide an overview of advances in our understanding of itch, workup of the itchy patient and management in different clinical scenarios.

Adam Friedman, MD
Treatment Updates of AK’s and Locally Advanced BCC with Levulan and Odomzo Respectively Bill Hanke, MD
Changing Treatment Paradigms to Improve Rosacea ClearanceJeffrey S. Fromowitz, MD, FAAD
8:30AM - 10:00AMGENERAL SESSION I
Psoriatic Arthritis for the Dermatologist

Psoriatic arthritis affects approximately 30% of patients with psoriasis and usually presents up to 10 years after the onset of psoriasis. Thus, the majority of patients with psoriatic arthritis should be under the care of dermatologists who should understand the importance of making an early psoriatic arthritis diagnosis to help prevent permanent joint destruction. This session will cover the important link between psoriasis and psoriatic arthritis, Dactylitis and enthesitis, early diagnosis of Psoriatic Arthritis, and ways to work with our Rheumatology colleagues to jointly manage psoriasis and psoriatic arthritis.

 

Alan Menter, MD
3-2-1 Contact: Practical Pearls for the Management of Allergic Contact Dermatitis

This lecture is designed to review common diagnostic dilemmas that occur when assessing a patient for allergic contact dermatitis. We will discuss how allergic contact dermatitis can complicate the assessment of eczematous dermatitis and how to diagnose and treat systemic allergic contact dermatitis.

Jonathan Zippin, MD
Does This Skin Cancer Really Need Mohs?

Mohs Micrographic Surgery is the gold standard for the removal of aggressive or high-risk skin cancers as well as cancers in locations of functional concern. However, not all skin cancers are created equally and fit this description. In this session, expert surgeons and dermatologic oncologists will discuss the breadth of cutaneous malignancies and what skin cancers should and should not be treated with Mohs Micrographic Surgery.

 

Sailesh Konda, MD; Vishal Patel, MD
Faculty Award PresentationJoel Cohen, MD
Live Injectable DemonstrationsSusan Weinkle, MD and Kavita Mariwalla, MD
10:00 AMCOFFEE BREAK IN EXHIBIT HALL
10:30AM - 12:30PMGENERAL SESSION II
Melasma: Why Can't We Do Better?

During this session, Dr. Ross will to compare various interventions in management of melasma.

Vic Ross, MD
An Evidence Based Approach to the Spectrum of Cutaneous Squamous Cell Carcinomas
Cutaneous squamous cell carcinoma is a ubiquitous but potentially deadly disease. But our lack of understanding around which tumors are truly deadly limits our ability to manage these cancers with high precision. Recent advances in how to stage tumors and new therapies to manage what once had little treatment options have armed us with new exciting tools.  In this session, the latest research and expert consensus on how to risk stratify the spectrum of squamous cell diseases, from low risk in situ lesions to high risk and aggressive tumors, will be presented, with a focus on an evidence based systematic approach to treatment.

Vishal Patel, MD
Facial Vessels: What Lies BeneathJoel Cohen, MD

What Does Your Aesthetic Eye See? Views from a Dermatologist and Plastic Surgeon

During this panel, patient photos will be presented for evaluation and discussion of treatment plans. Dr. Weinkle and Dr. Yee will share injection techniques and how to train your aesthetic eye to see what areas will benefit from treatment.

Susan Weinkle, MD; Jackie Yee, MD

Vascular Complications of Fillers: Treatment Algorithm For Impending Necrosis

Vascular compromise is one of the most worrisome complications of soft-tissue augmentation treatments.  Injectors should be aware of this condition and some potential treatment regimens. Dr. Cohen will review features of cutaneous necrosis to aid in diagnosis, discuss treatment strategies, including hyaluronidase enzyme injections and other modalities and show specific cases where management of impending necrosis led to a good overall outcome.

Joel Cohen, MD
Live Injectables DemonstrationSusan Weinkle, MD; Jackie Yee, MD
12:30PMLUNCH BREAK IN THE EXHIBIT HALL - Registered Attendees Only
12:45PM - 1:45PMLUNCH WORKSHOPS
Lunch Roundtable Discussions in the Exhibit Booth 307 - Introducing New Seysara™ (sarecycline) Tablets
12:45 - 1:45 PMABSORICA LD™ (Isotretinoin) Capsules: An Innovative, Micronized Treatment to Help Your Patients Move Beyond Severe Recalcitrant Nodular AcneLeon Kircik, MD
2:00PM - 4:15PMGENERAL SESSION III

Hidradenitis Suppurativa: Everything and the Kitchen Sink to Optimize Treatment Outcomes

This presentation will tackle the unmet clinical needs of patients presenting with hidradenitis suppurativa.  These include the importance and unfortunate rarity of early recognition and diagnosis, more off the on-label therapeutic options and the central role of patient and non-dermatology provider education and family/caregiver support.  An overview of commonly encountered complications of HS, clinical pearls on managing common comorbidities and other expert strategies will be offered.

Adam Friedman, MD

What's New in Medical, Surgical, and Cosmetic Treatments for Hair Loss
Dr. McMichael will discuss the appropriate clinical evaluation of alopecia patients and order appropriate complementary studies, review the most common scarring and non-scarring forms of hair loss and the most effective treatments and treatments on the horizon for most common forms of hair loss. She will also discuss how to maximize treatment options in patients with more than one form of alopecia and improve compliance for multiple treatments.

 

Amy McMichael, MD

Off Label Offerings: An Evidenced Based and Practical Guide for Dermatologic Applications

So many diseases, so few FDA approved indications. Between the mind numbing time and cost from bench to bottle, it is no surprise that we as masters of the integument are the off label bandits, marrying our wealth of knowledge on the pathophysiology of skin diseases to the mechanisms by which medications work to create an evidenced based armament of therapies for both common and rare diseases alike. Where a primary care physician sees a blood pressure medication, we see an effective medication for acne. A medication for malaria you say? We use it for a plethora of complex diseases ranging from Lupus to scarring hair loss. The lengthy list of medications used off label in dermatology continues to grow and for good reason and fortune. In this lecture, I will review the evidence supporting several of the more commonly used off label therapies in dermatology, provide practical pearls on clinical use, and share my own experience along the way.

Adam Friedman, MD
Cosmeceuticals : What's Real and What's NotKavita Mariwalla, MD
Platelet Rich Plasma (PRP): “The process is the product”

PRP is new and exciting treatment for delivery growth factors to the skin via a high concentration of platelets.  Its potential uses will be explored in detail including some of the controversies surrounding its use.
Terrence Keaney, MD
Live DemonstrationTBD
What's New in Combination Treatments - Mixology in Dermatology

Combination therapies are increasingly popular in rejuvenation. At the conclusion of this session, attendees will be able to understand the role of various energy-based interventions in management of skin damage.

Vic Ross, MD
4:30 - 5:30PMAFTERNOON WORKSHOPS
Employment Contract Negotiations & Private Partnerships in Dermatology - What You Should KnowRon Lebow, Esq.
Fellowships: What You Should Know Before Applying - with Q&A Bill Hanke, MDBill Hanke, MD

Non-Surgical Treatment of BCC

Multiple non-surgical alternatives exist for the treatment of basal cell carcinoma. This session will cover these alternatives in detail including topical, energy-based and systemic therapies for BCC.

James Spencer, MD
5:30 PMDINNER SYMPOSIUM AND EVENING EVENTS
5:30 PMEvaluating Clinical Trials 

Open to 75 Dermatology Residents and Fellows. First come, first served. 
Leon H. Kircik, MD

MONDAY, JANUARY 20

8:00AM - 10:00AMGENERAL SESSION IOPEN TO ALL ATTENDEES

How to Improve Photography in Your Clinical Practice - My Top 10 Pearls

Clinical photography is a critical tool for the dermatologist and has rapidly become standard of care in the digital era.  While a point-and-click approach to photography is sufficient for some circumstances, there are some simple tricks and techniques that will elevate your photography to a new level of professionalism.

Justin Finch, MD
Media Relations in Dermatology
Becoming a media expert can help grow a dermatology practice. But how do you begin? Taught by a public relations and communications consultant, this session will outline how everyday patient interactions can help prepare you for a media interview. Learn how to do your own media pitching, find out what makes a successful interview, and understand the do’s and don’ts of working with the media.

Allison Sit

Genoderms Made Ludicrously Easy - Pigmentation Disorders

Genoderms are hard! There are more than 600 diseases and genes with important skin manifestations, and dermatologists are the only specialists with the unique complete skill set to recognize and diagnose these diseases. But where do you begin?

We will use high-yield cartoons and mnemonics to emphasize the important features of a pigmentation disorders.

Justin Finch, MD

Starting Your Own Practice - Expert Panel with Q&A

Starting your own dermatology practice can be daunting and challenging. The three-member panel will discuss their motivations for going into private practice and offer expert advice for young physicians considering starting their own practice. Dr. Keaney will discuss his experience starting his practice in July 2017 and growing it in a large, thriving full service (medical, aesthetic and clinical research) dermatology practice. Dr. Finch and Dr. Jain will discuss a timeline for launching a new practice, branding, marketing, public relations and much more. 

Sima Jain, MD - Terrence Keaney, MD - Justin Finch, MD
10:00AM - 12:00PMMINI COSMETIC SYMPOSIUM - 10:00AM - 12:00PM HANDS-ON SESSION PARTICIPATION OPEN TO RESIDENTS & FELLOWS ONLY
Facial Anatomy & Patient Assessment BasicsKavita Mariwalla, MD
Avoiding Danger Zones & Managing ComplicationsKavita Mariwalla, MD
How to Select & Use Injectables (Soft Tissue Fillers and Neuromodulators)Kavita Mariwalla, MD

Live Injectables Demonstrations (Including Lower, Mid, and Upper Face)

 

All attendees are welcome to observe hands-on training activity, only residents will receive hands-on materials.

Kavita Mariwalla, MD and Terrence Keaney, MD
CONFERENCE CONCLUDES

Conference Chairs

James Spencer, MD, MS

James Spencer, MD, MS

Conference Chair

Perry Robins, MD

Perry Robins, MD

Conference Chair Emeritus

Vice Conference Chairs

Joel L. Cohen, MD

Joel L. Cohen, MD

Vice Conference Chair

Susan H. Weinkle, MD

Susan H. Weinkle, MD

Vice Conference Chair

Medical Director

Adam Friedman, MD, FAAD

Adam Friedman, MD, FAAD

Medical Director

2020 Elite Presenting Faculty

Shino Bay Aguilera, DO

Shino Bay Aguilera, DO

Faculty

Justin Finch, MD

Justin Finch, MD

Faculty

Robert Gotkin, MD

Robert Gotkin, MD

Faculty

Jeremy Green, MD

Jeremy Green, MD

Faculty

Bill Hanke, MD

Bill Hanke, MD

Faculty

John Harris, MD

John Harris, MD

Faculty

Sima Jain, MD

Sima Jain, MD

Faculty

Terrence Keaney, MD

Terrence Keaney, MD

Faculty

Leon Kircik, MD

Leon Kircik, MD

Faculty

A. Yasmine Kirkorian, MD

A. Yasmine Kirkorian, MD

Faculty

Sailesh Konda, MD

Sailesh Konda, MD

Faculty

Angelo Landriscina, MD

Angelo Landriscina, MD

Faculty

Kavita Mariwalla, MD

Kavita Mariwalla, MD

Faculty

Amy McMichael, MD

Amy McMichael, MD

Faculty

Alan Menter, MD

Alan Menter, MD

Faculty

David Miller, MD

David Miller, MD

Faculty

Vishal Patel, MD

Vishal Patel, MD

Faculty

Desiree Ratner, MD

Desiree Ratner, MD

Faculty

E. Victor Ross, MD

E. Victor Ross, MD

Faculty

Deborah S. Sarnoff, MD

Deborah S. Sarnoff, MD

Faculty

Linda Stein Gold, MD

Linda Stein Gold, MD

Faculty

Erik Stratman, MD

Erik Stratman, MD

Faculty

Jackie Yee, MD

Jackie Yee, MD

Faculty

Jonathan Zippin, MD

Jonathan Zippin, MD

Faculty

ODAC is organized and produced by SanovaWorks.